Filter Results:
(313)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
Show Results For
- All HBS Web
(313)
- People (1)
- News (124)
- Research (147)
- Multimedia (13)
- Faculty Publications (95)
- 10 Aug 2021
- News
It’s Time for CEOs to Mandate COVID Vaccinations for All Employees
- 18 Mar 2020
- News
Merck CEO Ken Frazier on the race for a coronavirus vaccine
- May 2020 (Revised April 2024)
- Case
Gavi and COVID-19: Pandemic of the Century
By: Tarun Khanna and Sid Misra
Gavi has helped immunize over 760 million children in the world's poorest countries over the past 20 years saving 13 million lives. How should Gavi respond to the need for a vaccine for the worldwide COVID-19 pandemic? View Details
Keywords: Vaccine; Pandemics; Healthcare; COVID-19; Health Pandemics; Health Care and Treatment; Emerging Markets; Crisis Management; Alliances
Khanna, Tarun, and Sid Misra. "Gavi and COVID-19: Pandemic of the Century." Harvard Business School Case 720-451, May 2020. (Revised April 2024.)
- 28 Apr 2020
- News
Vaccine Push Has Bill Gates, Science and Economics Going for It
- October 2024
- Article
Greater Covid-19 Vaccine Uptake among enrollees Offered Health and Social Needs Case Management: Results from a Randomized Trial
By: Margae Knox, Elizabeth A. Hernandez, Daniel M. Brown, Jennifer Ahern, Mark D. Fleming, Crystal Guo and Amanda L. Brewster
The CommunityConnect case management program for Medicaid beneficiaries is run by Contra Costa Health, a county safety net health system in California. Case management infrastructure modestly improved Covid-19 vaccine uptake in a population of Medicaid beneficiaries... View Details
Keywords: Health Care and Treatment; Health Pandemics; Medical Specialties; Programs; Human Needs; Welfare; Health Industry; California
Knox, Margae, Elizabeth A. Hernandez, Daniel M. Brown, Jennifer Ahern, Mark D. Fleming, Crystal Guo, and Amanda L. Brewster. "Greater Covid-19 Vaccine Uptake among enrollees Offered Health and Social Needs Case Management: Results from a Randomized Trial." Health Services Research 59, no. 5 (October 2024).
- March 13, 2020
- Editorial
Scale the Price for a Coronavirus Vaccine by the Harm it Averts
By: Amitabh Chandra
Chandra, Amitabh. "Scale the Price for a Coronavirus Vaccine by the Harm it Averts." Boston Globe (March 13, 2020).
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical devices/diagnostics Precision Medicine Public Health Women's Health 17 Aug 2022 Bringing the Next Pandemic View Details
- 17 Aug 2021
Behind the Scenes of Writing a Case Study: When manufacturing and a mass vaccination site intersect
How can business leaders play a role in solving society’s biggest problems? How do HBS professors select and write case studies on relevant and current topics? How can manufacturing expertise improve inefficiencies at a mass vaccination... View Details
- May 2014 (Revised January 2015)
- Case
Vaxess Technologies, Inc.
By: John A. Quelch and Margaret L. Rodriguez
In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details
Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Medical Devices and Supplies Industry
Quelch, John A., and Margaret L. Rodriguez. "Vaxess Technologies, Inc." Harvard Business School Case 514-107, May 2014. (Revised January 2015.)
- 24 May 2013
- News
Aimed at Increasing Vaccine Access, Vaxess Raises the First Part of a $3.75M Series A
Keywords: Health, Social Assistance
- 01 Aug 2013
- News
A Cure for Cold Storage
percent of the children are vaccinated against the virus. And the price of the vaccine is negligible, says Schrader—around 5 or 10 cents. "It's not cost that limits it," he says, but rather infrastructure:... View Details
- October 2021 (Revised January 2022)
- Supplement
Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)
By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Hill, Linda A., and Emily Tedards. "Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)." Harvard Business School Supplement 422-041, October 2021. (Revised January 2022.)